Current position:Home >Product >
1-[1-(Toluene-4-sulfonyl)-1H-benzoiMidazol-2-yl]-piperidin-3-ol, 98+% C19H21N3O3S, MW: 371.46
1-[1-(Toluene-4-sulfonyl)-1H-benzoiMidazol-2-yl]-piperidin-3-ol, 98+% C19H21N3O3S, MW: 371.46(1146080-28-5)
- Name: 1-[1-(Toluene-4-sulfonyl)-1H-benzoiMidazol-2-yl]-piperidin-3-ol, 98+% C19H21N3O3S, MW: 371.46
- Synonyms:2-(3-hydroxypiperidyl)-1-[(4-methylphenyl)sulfonyl]benzimidazole;1-[1-(Toluene-4-sulfonyl)-1H-benzoimidazol-2-yl]-piperidin-3-ol;
- Molecular Formula:C19H21N3O3S
- Molecular Weight:371.45
- CAS Registry Number:1146080-28-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1146080-28-5 1-[1-(Toluene-4-sulfonyl)-1H-benzoimidazol-2-yl]-piperidin-3-ol
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.1146080-28-5 1-[1-(Toluene-4-sulfonyl)-1H-benzoiMidazol-2-yl]-piperidin-3-ol, 98+% C19H21N3O3S, MW: 371.46
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:1-[1-(Toluene-4-sulfonyl)-1H-benzoiMidazol-2-yl]-piperidin-3-ol, 98+% C19H21N3O3S, MW: 371.46
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] - Hangzhou Hysen Pharma co.,Ltd.
Other Product
- 1184997-21-4/3-[(3-Fluorobenzyl)oxy]piperidine hydrochloride
- 1185310-55-7/2-(Piperidin-3-yloxy)-pyridine hydrochloride, 98+% C10H15ClN2O, MW: 214.69
- 338411-78-2/3'-Nitro-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-ol, 98+% C10H13N3O3, MW: 223.23
- 1185312-53-1/3-HydroxyMethyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-3'-carboxylic acid Methyl ester hydrochloride, 98+% C13H19ClN2O3, MW: 286.76
- 1185308-97-7/2-[(Piperidin-4-ylMethyl)-aMino]-nicotinic acid Methyl ester dihydrochloride, 98+% C13H21Cl2N3O2, MW: 322.23
- 1185307-70-3/1-(3-Chloro-quinoxalin-2-yl)-piperidin-3-ylaMine hydrochloride, 98+% C13H16Cl2N4, MW: 299.20
- 1185309-86-7/3-AMino-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-3'-carboxylic acid Methyl ester dihydrochloride, 98+% C12H19Cl2N3O2, MW: 308.21
- 1185307-66-7/2-(Piperidin-3-ylaMino)-nicotinic acid Methyl ester dihydrochloride, 98+% C12H19Cl2N3O2, MW: 308.21
- 1185309-53-8/1-(3-Chloro-quinoxalin-2-yl)-piperidin-4-ylaMine hydrochloride, 98+% C13H16Cl2N4, MW: 299.20
- 1185307-29-2/3,4,5,6-Tetrahydro-2H-[1,2']bipyridinyl-4,3'-dicarboxylic acid 3'-Methyl ester hydrochloride, 98+% C13H17ClN2O4, MW: 300.74
- 1185307-64-5/(3-Chloro-quinoxalin-2-yl)-piperidin-4-yl-aMine hydrochloride, 98+% C13H16Cl2N4, MW: 299.20
- 1185308-09-1/2-[(Piperidin-3-ylMethyl)-aMino]-nicotinic acid Methyl ester dihydrochloride, 98+% C13H21Cl2N3O2, MW: 322.24
- 939986-43-3/3-(3-Chloro-quinoxalin-2-yloxyMethyl)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C19H24ClN3O3, MW: 377.87
- 1185307-21-4/4-AMino-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-3'-carboxylic acid Methyl ester dihydrochloride, 98+% C12H19Cl2N3O2, MW: 308.21
- 1065483-94-4/[1-(1-Ethyl-1H-benzoiMidazol-2-yl)-piperidin-3-yl]-Methanol, 98+% C15H21N3O, MW: 259.35
- 1065483-91-1/1-(1-Ethyl-1H-benzoiMidazol-2-yl)-piperidin-3-ol, 98+% C14H19N3O, MW: 245.33
- 939986-62-6/3-(3-Chloro-quinoxalin-2-yloxy)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C18H22ClN3O3, MW: 363.84
- 1065483-90-0/1-(1-Ethyl-1H-benzoiMidazol-2-yl)-piperidin-4-ol, 98+% C14H19N3O, MW: 245.33
- 939986-42-2/4-(3-Chloro-quinoxalin-2-yloxy)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C18H22ClN3O3, MW: 363.84
- 1146080-28-5/1-[1-(Toluene-4-sulfonyl)-1H-benzoiMidazol-2-yl]-piperidin-3-ol, 98+% C19H21N3O3S, MW: 371.46
- 1146080-06-9/3-[4-(Morpholine-4-carbonyl)-phenoxy]-piperidine-1-carboxylic acid tert-butyl ester, 98+% C21H30N2O5, MW: 390.48
- 1185319-90-7/Piperidin-4-ylMethyl-[1-(toluene-4-sulfonyl)-1H-benzoiMidazol-2-yl]-aMine hydrochloride, 98+% C20H25ClN4O2S, MW: 420.96
- 1146080-05-8/4-[4-(Morpholine-4-carbonyl)-phenoxy]-piperidine-1-carboxylic acid tert-butyl ester, 98+% C21H30N2O5, MW: 390.48
- 1146080-02-5/4-[2-(Morpholine-4-carbonyl)-phenoxy]-piperidine-1-carboxylic acid tert-butyl ester, 98+% C21H30N2O5, MW: 390.48
- 1185308-14-8/Piperidin-3-ylMethyl-[1-(toluene-4-sulfonyl)-1H-benzoiMidazol-2-yl]-aMine hydrochloride, 98+% C20H25ClN4O2S, MW: 420.96
- 1185309-92-5/Piperidin-4-yl-[1-(toluene-4-sulfonyl)-1H-benzoiMidazol-2-yl]-aMine hydrochloride, 98+% C19H23ClN4O2S, MW: 406.94
- 12768-45-5/SODIUM DODECYL SULFATE
- 1185319-71-4/4-(2-Methyl-5-phenyl-pyrrol-1-yl)-piperidine hydrochloride, 98+%
- 1185319-66-7/4-(2-Methyl-5-phenyl-pyrrol-1-ylMethyl)-piperidine hydrochloride, 98+%
- 1185318-18-6/tert-butyl-4-(3-(cyclopropylaMino)quinoxalin-2-yloxy)piperidine-1-carboxylate, 98+% C21H28N4O3, MW: 384.47